EUZ Stock Overview
Through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for EUZ from our risk checks.
Eckert & Ziegler SE Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €44.84 |
52 Week High | €49.50 |
52 Week Low | €28.92 |
Beta | 1.22 |
1 Month Change | -3.28% |
3 Month Change | 20.47% |
1 Year Change | 15.09% |
3 Year Change | -51.10% |
5 Year Change | 85.48% |
Change since IPO | 623.23% |
Recent News & Updates
Investors Met With Slowing Returns on Capital At Eckert & Ziegler (ETR:EUZ)
Jun 05Is Now An Opportune Moment To Examine Eckert & Ziegler SE (ETR:EUZ)?
May 13Eckert & Ziegler SE (ETR:EUZ) Investors Are Less Pessimistic Than Expected
Apr 27Recent updates
Investors Met With Slowing Returns on Capital At Eckert & Ziegler (ETR:EUZ)
Jun 05Is Now An Opportune Moment To Examine Eckert & Ziegler SE (ETR:EUZ)?
May 13Eckert & Ziegler SE (ETR:EUZ) Investors Are Less Pessimistic Than Expected
Apr 27Here's Why Eckert & Ziegler (ETR:EUZ) Can Manage Its Debt Responsibly
Apr 12Slowing Rates Of Return At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Leave Little Room For Excitement
Mar 06What Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) P/E Is Not Telling You
Jan 04Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has A Pretty Healthy Balance Sheet
Dec 20Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Hasn't Managed To Accelerate Its Returns
Nov 15What Is Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) Share Price Doing?
Oct 01A Look At The Intrinsic Value Of Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)
Aug 22These 4 Measures Indicate That Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is Using Debt Reasonably Well
Jul 16Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Jun 22The Return Trends At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Look Promising
May 17Is Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ) Potentially Undervalued?
Mar 20Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns Have Hit A Wall
Jan 24We Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Can Stay On Top Of Its Debt
Oct 27Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Oct 05Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has Some Way To Go To Become A Multi-Bagger
Aug 21Is Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) A Risky Investment?
Jul 21Is There Now An Opportunity In Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Jun 13Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Will Pay A Larger Dividend Than Last Year At €0.50
May 13Returns At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Are On The Way Up
May 09Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50
Apr 24Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50
Mar 27Do Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Earnings Warrant Your Attention?
Mar 25When Should You Buy Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Feb 17Investors Will Want Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Growth In ROCE To Persist
Jan 31Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today
Dec 13Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns On Capital Are Heading Higher
Nov 01Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today
Sep 14Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Have The Makings Of A Multi-Bagger
Jul 29Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is An Interesting Stock
Jun 11Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is Experiencing Growth In Returns On Capital
Apr 30The Case For Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ): Could It Be A Nice Addition To Your Dividend Portfolio?
Apr 02Calculating The Intrinsic Value Of Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)
Mar 15Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 25Are Institutions Heavily Invested In Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) Shares?
Jan 29Shareholder Returns
EUZ | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -6.9% | -2.4% | -3.1% |
1Y | 15.1% | -2.2% | -0.5% |
Return vs Industry: EUZ exceeded the German Medical Equipment industry which returned -1% over the past year.
Return vs Market: EUZ exceeded the German Market which returned 1% over the past year.
Price Volatility
EUZ volatility | |
---|---|
EUZ Average Weekly Movement | 5.7% |
Medical Equipment Industry Average Movement | 4.5% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: EUZ's share price has been volatile over the past 3 months.
Volatility Over Time: EUZ's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | 1,072 | Harald Hasselmann | www.ezag.com |
Eckert & Ziegler SE, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma.
Eckert & Ziegler SE Fundamentals Summary
EUZ fundamental statistics | |
---|---|
Market cap | €934.71m |
Earnings (TTM) | €33.87m |
Revenue (TTM) | €255.78m |
27.6x
P/E Ratio3.7x
P/S RatioIs EUZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EUZ income statement (TTM) | |
---|---|
Revenue | €255.78m |
Cost of Revenue | €131.99m |
Gross Profit | €123.79m |
Other Expenses | €89.91m |
Earnings | €33.87m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 09, 2024
Earnings per share (EPS) | 1.63 |
Gross Margin | 48.40% |
Net Profit Margin | 13.24% |
Debt/Equity Ratio | 10.6% |
How did EUZ perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield31%
Payout RatioDoes EUZ pay a reliable dividends?
See EUZ dividend history and benchmarksEckert & Ziegler dividend dates | |
---|---|
Ex Dividend Date | Jun 27 2024 |
Dividend Pay Date | Jul 01 2024 |
Days until Ex dividend | 12 days |
Days until Dividend pay date | 16 days |
Does EUZ pay a reliable dividends?
See EUZ dividend history and benchmarks